Phase 3 ELEVATE TN Study in CLL @SeattleCCA

Phase 3 ELEVATE TN Study in CLL @SeattleCCA

User Photo
obr

5 months
28 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Chaitra Ujjani, MD, Associate Professor, @SeattleCCA University of Washington, Fred Hutchinson Cancer Research Center, tells us about the results of the Phase 3 ELEVATE TN study, investigating acalabrutinib combined with obinutuzumab or alone versus obinutuzumab plus chlorambucil in patients with treatment-naive chronic lymphocytic leukemia (CLL).
Up Next Autoplay
User Photo